在TRAVERSE试验中,男性的抑郁症综合征与阴性腺缺陷:对替代疗法的反应
Shalender Bhasin1, Stuart Seidman2, Thomas G Travison3
1Research Program in Men's Health: Aging and Metabolism, Boston Claude D. Pepper Older Americans Independence Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
The Journal of clinical endocrinology and metabolism
|January 11, 2024
概括
替代疗法 (TRT) 在低阴茎男性中提供适度的情绪和能量改善. 然而,TRT在本研究人群中没有显著影响抑郁症或认知功能.
科学领域:
- 内分泌学 在内分泌学.
- 男人的健康 男人的健康
- 精神病学是一个精神病学.
背景情况:
- 丸激素对患有阴性腺的男性抑郁症状的影响尚未完全理解.
- 阴性腺缺陷症在中年和老年男性中普遍存在,通常与心血管疾病和抑郁症状并发.
研究的目的:
- 为了评估替代疗法 (TRT) 在改善男性下阴腺抑郁症症状方面的疗效.
- 评估TRT对TRAVERSE试验中特定子组的情绪,能量,睡眠和认知的影响.
主要方法:
- 一个随机的,安慰剂控制的,双盲试验,涉及5204名45-80岁的男性,患有阴道腺缩症和心血管风险.
- 参与者被评估是否有晚期发病,低度持续性抑郁障碍 (LG-PDD) 和显著的抑郁症状.
- 干预涉及1.62%的透皮或安慰剂凝,在三个子组测量结果.
主要成果:
- 虽然LG-PDD很少见 (1.5%),但显著的抑郁症状很常见 (50.8%).
- 对于LG-PDD子组来说,TRT没有显示任何显著的好处.
- 对于有明显抑郁症状的男性和整体队伍来说,TRT与适度但显著的情绪和能量改善有关.
结论:
- 抑郁症症状在男性中很常见,但LG-PDD不常见.
- 替代疗法对低阴腺男性的情绪和能量提供了轻微的益处,无论基线抑郁症状的严重程度如何.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
237
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
237
Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41
Disorders of the Male Reproductive System
419
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
419
Testosterone: Functions and Regulation
670
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
670
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
394
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
394
Menopause
166
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
166


